Fischer Medical [FISCHER] vs Nureca [NURECA] Detailed Stock Comparison

Fischer Medical Ventures Ltd.

BSE
Loading...

Nureca Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Fischer Medical Ventures Ltd. wins in 7 metrics, Nureca Ltd. wins in 12 metrics, with 0 ties. Nureca Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Fischer Medical Ventures Ltd. Nureca Ltd. Better
P/E Ratio (TTM) 63.39 24.00 Nureca Ltd.
Price-to-Book Ratio 6.72 1.54 Nureca Ltd.
Debt-to-Equity Ratio 10.26 2.71 Nureca Ltd.
PEG Ratio 0.13 -0.03 Fischer Medical Ventures Ltd.
EV/EBITDA 57.80 42.40 Nureca Ltd.
Profit Margin (TTM) 15.17% 7.43% Fischer Medical Ventures Ltd.
Operating Margin (TTM) 20.57% 6.94% Fischer Medical Ventures Ltd.
EBITDA Margin (TTM) 20.57% 6.94% Fischer Medical Ventures Ltd.
Return on Equity 0.36% 0.44% Nureca Ltd.
Return on Assets (TTM) 0.26% 0.40% Nureca Ltd.
Free Cash Flow (TTM) $-927.26M $-234.06M Nureca Ltd.
1-Year Return -57.40% -17.00% Nureca Ltd.
Price-to-Sales Ratio (TTM) 9.41 1.85 Nureca Ltd.
Enterprise Value $24.93B $2.54B Fischer Medical Ventures Ltd.
EV/Revenue Ratio 9.59 1.78 Nureca Ltd.
Gross Profit Margin (TTM) 50.38% 36.32% Fischer Medical Ventures Ltd.
Revenue per Share (TTM) $3 $148 Nureca Ltd.
Earnings per Share (Diluted) $0.59 $11.04 Nureca Ltd.
Beta (Stock Volatility) -0.03 0.61 Fischer Medical Ventures Ltd.

Fischer Medical Ventures Ltd. vs Nureca Ltd. Stock Performance Analysis

Loading Price Chart...

FISCHER
NURECA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Fischer Medical Ventures Ltd.-1.55%10.75%2.12%7.06%-21.38%-14.16%
Nureca Ltd.1.53%2.79%-13.68%-4.29%-16.61%-24.18%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Fischer Medical Ventures Ltd.-57.40%-70.45%1,348.00%-12.14%101.56%439.49%
Nureca Ltd.-17.00%-36.56%-85.03%-65.77%-65.77%-65.77%

Performance & Financial Health Analysis: Fischer Medical Ventures Ltd. vs Nureca Ltd.

MetricFISCHERNURECA
Market Information
Market Cap i₹24.43B₹2.67B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i71,1589,109
90 Day Avg. Volume i126,15414,978
Last Close₹35.64₹235.65
52 Week Range₹31.13 - ₹124.20₹204.00 - ₹343.00
% from 52W High-71.30%-31.30%
All-Time High₹2,386.00 (Apr 21, 2008)₹2,315.00 (Oct 04, 2021)
% from All-Time High-98.51%-89.82%
Growth Metrics
Quarterly Revenue Growth7.61%0.50%
Quarterly Earnings GrowthN/A0.27%
Financial Health
Profit Margin (TTM) i0.15%0.07%
Operating Margin (TTM) i0.21%0.07%
Return on Equity (TTM) i0.00%0.00%
Debt to Equity (MRQ) i10.262.71
Cash & Liquidity
Book Value per Share (MRQ)₹5.57₹172.08
Cash per Share (MRQ)₹0.67₹9.15
Operating Cash Flow (TTM) i₹-1,015,668,000₹-172,050,000
Levered Free Cash Flow (TTM) i₹12.08M₹8.46M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A₹0.00

Valuation & Enterprise Metrics Analysis: Fischer Medical Ventures Ltd. vs Nureca Ltd.

MetricFISCHER (Apr 24, 2026)NURECA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i63.3924.00
Forward P/E iN/AN/A
PEG Ratio i0.13-0.03
Price to Sales (TTM) i9.411.85
Price to Book (MRQ) i6.721.54
Market Capitalization
Market Capitalization i₹24.43B₹2.67B
Enterprise Value i₹24.93B₹2.54B
Enterprise Value Metrics
Enterprise to Revenue i9.591.78
Enterprise to EBITDA i57.8042.40
Risk & Other Metrics
Beta i-0.030.61
Book Value per Share (MRQ) i₹5.57₹172.08

Financial Statements Comparison: Fischer Medical Ventures Ltd. vs Nureca Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricFISCHER (2025)NURECA (2025)
Revenue/Sales i1.11B1.10B
Cost of Goods Sold i915.90M687.02M
COGS % of Revenue i82.7%62.6%
Gross Profit i191.09M409.59M
Gross Margin i17.3%37.4%
Research & Development iN/AN/A
Operating Income (EBIT) i30.61M-98.28M
Operating Margin i2.8%-9.0%
EBITDA i53.47M620,000
EBITDA Margin i4.8%0.1%
Pre-Tax Income i22.23M13.43M
Pre-Tax Income % of Revenue i2.0%1.2%
Income Tax i10.15M4.97M
Income Tax % of Revenue i0.9%0.5%
Net Income (Profit) i12.08M8.46M
Profit Margin i1.1%0.8%

Balance Sheet & Liquidity Metrics

MetricFISCHER (2025)NURECA (2025)
Cash & Equivalents i1.04B32.41M
Total Current Assets i3.65B1.90B
Total Current Assets % of Revenue i330.0%173.2%
Total Current Liabilities i1.02B123.99M
Total Current Liabilities % of Revenue i92.0%11.3%
Long-Term Debt i172.06M25.90M
Long-Term Debt % of Revenue i15.5%2.4%
Total Shareholders Equity i3.38B1.94B
Retained Earnings i29.05M868.20M
Retained Earnings % of Revenue i2.6%79.2%
Property, Plant & Equipment i89.03M70.13M

Cash Flow Statement Comparison

MetricFISCHER (2025)NURECA (2025)
Operating Cash Flow i-1.02B-172.05M
Operating Cash Flow % of Revenue i-91.8%-15.7%
Capital Expenditures i-59.87M-42.94M
Free Cash Flow i-927.26M-234.06M
FCF Margin i-83.8%-21.3%
Debt Repayment iN/A-1.96M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricFISCHERNURECA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i654.52M9.54M
Float Shares i164.93M2.75M
% Held by Insiders i76.28%68.13%
% Held by Institutions i2.54%0.00%
% Held by Public i21.18%31.87%

Dividend Analysis & Yield Comparison: Fischer Medical Ventures Ltd. vs Nureca Ltd.

MetricFISCHERNURECA
Last 12-Month Dividend iN/A₹0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A₹0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/A₹0.00
Ex-Dividend DateN/AN/A